Resources  /  Costa Rica

Costa Rica's minimum lab price list and why tests cost what they do

Two different machines explain almost the whole price list. Once you can see which test runs on which, nothing on a quote is mysterious.

Educational — not a recommendation to take anything

A published floor, not a market

The Colegio de Microbiólogos y Químicos Clínicos publishes a Lista Oficial de Precios Mínimos de Pruebas de Laboratorio — an official schedule of minimum prices, binding on its members through the colegio's ethics code and the regulation governing the microbiology service statute. The most recent published edition we have been able to find is the 2019 one, checked in October 2026.

So a quoted price is a floor plus whatever the laboratory adds. A laboratory may charge more. It may not charge less.

What the figures look like

These are the colegio minimums for the tests a metabolic panel is usually built from. We have cross‑checked them against a published 2026 retail catalogue from a national laboratory chain, and the two agree within a few per cent on almost every line — seven years apart. These prices barely move.

TestMinimumType of assay
Creatinina₡8,000Automated chemistry
Glicemia en ayunas₡8,500Automated chemistry
ALT (SGPT)₡12,000Automated chemistry
AST₡12,000Automated chemistry
Hemograma completo₡13,000Haematology analyser
Hemoglobina glicosilada (HbA1c)₡18,000Chromatography or immunoassay
Insulina en ayunas₡18,000Immunoassay
Ferritina₡18,000Immunoassay
hs‑CRP₡18,500Immunoassay
TSH₡19,000Immunoassay
Vitamina B12₡22,000Immunoassay
Perfil de lípidos₡23,000Automated chemistry, four analytes
IGF‑1₡27,000Immunoassay
Vitamina D 25‑OH₡32,500Immunoassay

Why the cheap tests are cheap

Look down the right‑hand column and the pattern is not clinical. It is mechanical.

Automated chemistry runs hundreds of samples an hour on a single analyser with inexpensive reagents. Glucose, creatinine, liver enzymes and the lipid panel all sit there, between ₡8,000 and ₡23,000 — and the lipid panel is four results for that price.

Immunoassays are antibody‑based. They use costlier reagents, run in batches, and carry more calibration and control burden per result. Every hormone, every vitamin, ferritin, insulin and IGF‑1 are in this group, and they cost two to four times as much each.

That is the whole explanation for why one thirteen‑test panel costs twice another. It is not markup. It is two different machines.

What the floor is supposed to buy

The figures are set by an evaluating commission, and the inputs are the ones you would expect: staff, premises, equipment, reagents and consumables, and external quality control — running known controls alongside your sample and submitting to outside proficiency testing.

None of that is visible in the result you receive, which is precisely the colegio's argument for a floor: in a pure price contest the invisible costs are the first to go. You can disagree with the policy and still find the reasoning useful, because it tells you exactly which costs a strikingly cheap test has probably removed.

The open question

In 2022 the executive moved to abolish minimum tariffs across several professions, and the colegio objected publicly. We have not been able to establish whether that decree took effect for clinical laboratories. If minimums are gone in practice, volume pricing becomes possible and everything above becomes a historical description rather than a rule.

We would rather tell you that than quote the list as settled law. If you are quoted meaningfully below these figures, that is the first thing to ask about — and the answer may be perfectly good.

How to use the list

  1. Ask for the list of analytes, not the name of the panel. A panel is only its contents.
  2. Add up the lines against the table above. You now know roughly what the floor is.
  3. Ask whether anything is referred to another laboratory, and whether that changes the turnaround.
  4. Ask whether the price includes a professional reading of the result, or only the numbers.

A panel's price is driven almost entirely by how many immunoassays are in it. That is also the right question clinically: each expensive test should be there because its result would change a decision, not because it rounds out a package.

Measure it rather than guess

Every patient starts the same way: thirty minutes with a physician, then a full biomarker panel drawn at a laboratory near you. Whether any medicine follows is your doctor’s decision, made after reading your results with you.

Measure my biomarkers